Webinar  |  

 

 

Webinar On Demand

SCOPE 2021 Virtual Summit

Hivemind: How to Best Leverage Sensors and Wearables in a Decentralized World, Using a Flexible Unified Approach

Register to watch the session

Sign up for recording

Alison Holland
Executive GM, Digital and Decentralized Solutions
Alison (Ali) Holland is Head of Decentralized Clinical Trials at Medable and is chartered to design and expand the end-to-end capabilities needed to partially or fully virtualize clinical studies, building on the commitment to reduce clinical trial times by 50%. Ali has over 20 years of experience in a variety of leadership roles, including Feasibility Head and Six Sigma Black Belt at Covance, and Business Head and global General Manager at Roche/Genentech in one of their therapeutic area business groups. Having been engaged in over 300 studies across Biotechs, Pharma and all geographies, Ali brings an incomparable level of insight and technical excellence on the matter of operational needs for sites and patients.

On- Demand Webinar Description

20-minute session, Hivemind: How to Leverage Sensors and Wearables in a Decentralized World Using a Flexible, Unified Approach

The industry has begun to discover that additional quality of life, disease state, and demographic data can often increase the chance of approval with regulatory agencies.


The result? Sponsors and CROs are rapidly increasing their usage of the latest sensors and wearables. 

The problem? However, it’s not that simple. As many have found out, managing multiple devices with different data sources can create as many problems as they solve. 

The solution? - A single, unified platform to govern all devices. 

How? Watch Ali Holland, Head of Decentralized Clinical Trials and Solutions, present at SCOPE 2021 as she helped attendees navigate how to utilize a single platform for virtually all sensors and wearables, and shares a number of relevant real-world examples and use cases.